Dr. Galson Approval Quotations

This approval is a welcome addition to the available defenses against the flu.

This approval is another example of the benefits of the Orphan Drug program, which provides incentives for the development of treatments for diseases affecting fewer than 200,000 patients in the United States a year. Until now, Pompe disease has had no approved treatment.